Among patients with diabetes receiving PCI, novel antidiabetic agents, compared with standard treatment, may reduce risk for acute kidney injury.

New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca's TAGRISSO® (osimertinib), as monotherapy and as the backbone for ...

The following is a summary of “L-shaped correlation between serum alpha-1-acid glycoprotein concentration and urinary albumin creatinine ratio in females: a cross-sectional survey,” published in the ...

The US Food and Drug Administration (FDA) has broadened the approval of Furoscix® (furosemide injection) to treat edema in ...

Walmart got some great deals on Tuesday, March 25 for you. Gardening, health, spring-cleaning and cooking products are ...